“The Food and Drug Administration has launched a new artificial intelligence tool for detecting cancer screening, the latest example of the agency’s further innovation around artificial intelligence and machine learning for health care applications.”
“The new tool, called GI Genius, is the first to use AI based on machine learning to help clinicians detect lesions in the colon in real time during a colonoscopy. The system was able to identify lab-confirmed adenomas or carcinomas in over 55% of patients, compared to 42% via a standard colonoscopy, said Dr. Matthew Diamond, chief medical officer for digital health at FDA’s Center for Devices and Radiological Health.”
“’AI has the potential to transform health care to better assist health care providers and improve patient care,’ Diamond told GovernmentCIO Media & Research. ‘When AI is combined with traditional screenings or surveillance methods, it could help find problems early on, when they may be easier to treat.'”
“To support artificial intelligence development, FDA is undertaking initiatives to standardize its data, said CDRH Associate Director for National Device Surveillance Dr. Gregory Pappas at an ATARC virtual event. Furthermore, FDA is working to develop new regulatory frameworks to better leverage real-world performance data, Diamond said.”
“By monitoring real-world performance, the agency can deliver more robust total product lifecycle-based oversight of medical devices, which are among the technologies benefitting from AI right now…” Read the full article here.
Source: New FDA AI Tool is Advancing Health Care — By Sarah Sybert, May 21, 2021. GovernmentCIO.
